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This study evaluated the eﬃcacy of the left atrial Maze procedure (Lt-maze) and unipolar
radiofrequency (RF) ablation as an additional procedure for the surgical treatment of atrial
ﬁbrillation (AF) in patient with other cardiac disease.
Methods and Results: The Maze procedure was performed in 100 consecutive patients with
AF: Lt-maze, 71 patients; bi-atrial Maze (Bi-maze), 29 patients. Cryoablation and RF ablation
were used in 82 and 18 patients, respectively. There were no in-hospital or early deaths.
Fourteen patients (14%) experienced postoperative complications. Seventy-ﬁve patients
(75%) were in sinus rhythm (SR) at discharge, 4 patients were in junctional rhythm, and 21
patients had AF. Two patients (2%) required permanent pacemaker implantation. The AF-free
rate at discharge was 79%, and the AF-free rate at hospital discharge did not diﬀer
signiﬁcantly between cryoablation and unipolar RF ablation (78% and 82%, respectively).
There were no signiﬁcant diﬀerences between these two groups in operative results, in terms
of the aortic cross-clamp time, cardiopulmonary bypass time, and AF-free rate, with the AF-
free rate not diﬀering signiﬁcantly in those who received single valve surgery (73% and 75%
in the cryoablation and unipolar RF ablation groups, respectively). The equipment cost of the
two procedures diﬀered greatly: 14,000 yen/patient for cryoablation and 250,000 yen/patient
for RF ablation. The AF-free rate did not diﬀer signiﬁcantly between Lt-maze (76%) and
Bi-maze (86%), including in those who received single valve surgery (72% and 79%,
respectively). The signiﬁcant predictors of AF recurrence in a univariate analysis were left
atrial diameter (p ¼ 0:03), duration of AF (p < 0:01), ﬁbrillation amplitude on ECG
(p ¼ 0:02), and cardiothoracic ratio (p < 0:01), with the duration of preoperative AF being
the only signiﬁcant predictor of AF in a multivariate analysis.
Conclusion: In this series, unipolar RF ablation for the Maze procedure was as eﬀective as
cryoablation at eliminating AF, and Lt-maze and Bi-maze were equipotent at restoring SR at
discharge.
(J Arrhythmia 2006; 22: 103–109)
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Introduction
The Maze procedure has been modiﬁed several
times since it was initially introduced by Cox and
colleagues,1–3) and is now recognized as the standard
technique for the treatment of atrial ﬁbrillation (AF).
This procedure was originally proposed as a right
and left atrial procedure, but its left atrial part (Lt-
maze) has received the most attention.4) The major
modiﬁcation in the history of the Maze procedure
has been from the cut-and-sew technique to cryoa-
blation. Nowadays radiofrequency (RF) energy—
which is another major modiﬁcation—is adopted in
linear ablation.5,6) Initially a unipolar RF ablation
was introduced clinically, with bipolar RF ablation
subsequently being adopted.7) The Maze procedure
has been performed as an additional technique rather
than as the main cardiac procedure in our institution.
This study evaluated the eﬃcacy of Lt-maze and
unipolar RF ablation as additional procedures in the
surgical treatment of AF.
Methods
Patient selection
From January 1997 through July 2004, 100
consecutive patients underwent surgery for AF using
Lt-maze or bi-atrial Maze (Bi-maze), with the
modiﬁed Cox-Maze III technique being adopted for
the latter. The linear blocked lines were ablated with
a cryosurgical system (Frigitronics CCS 200, Cooper
Surgical, Shelton, CT); from September 2002, a
unipolar RF ablation system (COBRA RF System,
Boston Scientiﬁc, San Jose, CA) was adopted for the
Maze procedure. Cryoablation was used for atrial
wall isolation in 82 patients, and RF ablation was
used in 18 patients; Lt-maze and Bi-maze were
performed in 71 and 29 patients, respectively. The
primary cardiac disease was valvular disease in 80
patients, ischemic disease in 12 patients, dilated
cardiomyopathy in 2 patients, atrial septal defect in 5
patients, and left atrial myxoma in 1 patient.
Surgical technique
All operations were performed at the same
institution by several surgeons. The procedures were
performed through a median sternotomy with car-
diopulmonary bypass (CPB) and an arrested heart.
The left atrium was opened from the right side
behind the interatrial groove. In addition to this
incision for left atrial entry, linear ablation lesions
were created superiorly and posteriorly in order to
isolate four pulmonary veins (PVs). The left atrial
appendage was either amputated and closed by
suture or circumferentially ablated around its base.
An ablation line was created from the base of this
appendage to the PVs island, and from the mitral
annulus to the PVs island. An inferior isthmus
ablation was performed in the right atrium (RA). In
the case of Bi-maze, an L-shaped incision was made
on the right atrial lateral wall laterally and posteri-
orly. A linear ablation lesion was created from the
posterior edge of this RA entry to the inferior vena
cava (IVC), and from the anterior end of this RA
incision to the tricuspid valve annulus. The right
atrial appendage was amputated and closed by
(A) (B)
PV
MV
LAA
Lt-maze Ablation lesion
FO
TV
CS
RAA
Right part of Bi-maze
ablation lesion
Figure 1 Schematic drawings of the
Maze procedures.
(A) left atrial part of the Maze procedure,
(B) right atrial part of the Maze proce-
dure
PV: pulmonary vein, MV: mitral valve,
LAA: left atrial appendage, CS: coronary
sinus, TV: tricuspid valve, FO: fossa
ovalis, RAA: right atrial appendage
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suture. An ablation line was created from the base of
the appendage to the tricuspid valve annulus. In case
of extremely dilated RA, another ablation line was
added on the RA free wall from the base of the
appendage. The additional linear ablation lesion was
created between the coronary sinus (CS) and IVC in
order to eliminate the atrial tachycardia originating
from CS and also reinforce the incomplete ablation
lesion of the RA entry–IVC around the cannulated
IVC.8–11) The atrial septum was ablated from both
atrial primary incisions to the fossa ovalis (Figure 1).
The cryoablation and RF ablation were performed at
60C for 90 seconds and 80C for 60 seconds,
respectively.
Data analysis
All analyses were performed retrospectively using
StatView software (ver. 5.0, SAS Institute, Cary,
NC). Continuous data are expressed as mean 
standard deviation values unless otherwise speciﬁed.
Diﬀerences in categorized variables were tested by
2 tests, and those in continuous variables were
tested by t tests or the Mann-Whitney U test. The
ablation technique and the Maze procedure were
compared separately in this study: for the ablation
comparison, the study cohort was divided into
cryoablation (Cryo) and RF-ablation (RF) groups;
and for the Maze procedure, the cohort was divided
into Bi-maze and Lt-maze groups. Furthermore,
these comparative analyses were performed in
patient subgroups that underwent a single valve
procedure including valvuloplasty or mitral or aortic
valve replacement with or without tricuspid valve
annuloplasty. Logistic regression analysis was used
to estimate the predictor of AF recurrence. First the
association between AF recurrence and each of the
other possible predictors was quantiﬁed by univari-
ate analysis, and then all predictors for which p <
0:10 in the univariate analysis were included in the
multivariate logistic regression model except tricus-
pid valve annuloplasty (TAP). P value of other
factors for which p > 0:10 in univariate analysis was
rather high, while TAP (p ¼ 0:13) was the only
factor in which the p value was fairly close to 0.10
and age was a generally related factor of AF. A
probability value of p  0:05 was considered indi-
cative of statistical signiﬁcance.
Results
There were no in-hospital or early deaths. Four-
teen patients (14%) experienced postoperative com-
plications: transient stroke in 3 patients, low output
syndrome in 9 patients, and embolism in 2 patients
(one was ischemic colitis and ischemic angiopathy in
the lower extremities with AF, the other was
embolism in the central artery of the retina in SR).
Seventy-ﬁve patients (75%) were in sinus rhythm
(SR) at discharge, 4 patients were in junctional
rhythm, and 21 patients had AF. Two patients (2%)
required permanent pacemaker implantation before
discharge. The AF-free rate at discharge was 79%.
Comparison 1: Ablation device—cryoablation vs.
unipolar RF ablation
The clinical characteristics of patients in the Cryo
and RF groups are listed in Table 1, for which the
only signiﬁcant diﬀerence was in gender: the
proportion of males was signiﬁcantly higher in the
RF group than in the Cryo group. The AF-free rates
at hospital discharge were 78.1% and 82.4% in the
Cryo and RF groups, respectively. There were no
signiﬁcant diﬀerences between the two groups in
operative results, in terms of the aortic cross-clamp
Table 1 Patients’ characteristics in ablation-device compar-
ison groups.
Cryoablation:
n ¼ 82
(single valve:
n ¼ 52)
RF ablation:
n ¼ 18
(single valve:
n ¼ 8)
Age, years 59:8 9:3 60:3 11:6 N.S.
(57:9 10:0) (58:5 11:5) N.S.
Gender, M/F 40/42 16/2 p < 0:01
(24/28) (8/0) p ¼ 0:013
AF duration, 6:3 5:7 7:1 7:9 N.S.
years (6:7 5:9) (8:9 8:7) N.S.
Fibrillation 0:20 0:09 0:21 0:08 N.S.
amplitude, mV (0:19 0:09) (0:21 0:10) N.S.
LAD, mm 49:1 9:1 50:3 7:2 N.S.
(50:5 9:6) (53:0 5:5) N.S.
( ): subgroup with single valve surgery, N.S.: no signiﬁcant,
LAD: left atrial diameter
Table 2 Operative results in ablation comparison.
Cryoablation RF ablation
ACC time, min 133:1 37:0 119:1 33:9 N.S.
(121:8 25:8) (113:0 30:0) (N.S.)
CPB time, min 189:1 47:0 180:6 48:7 N.S.
(175:9 38:8) (170:8 56:6) (N.S.)
Deﬁbrillation rate, % 78:1 82:4 N.S.
(73:1) (75:0) (N.S.)
( ): subgroup with single valve surgery, ACC: aortic cross-
clamp, CPB: cardiopulmonary bypass
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(ACC) time, CPB time, and AF-free rate. In those
who received single valve surgery, the AF-free rates
at hospital discharge were 73.1% and 75.0% in the
Cryo and RF groups, respectively, and there was no
signiﬁcant diﬀerence between these groups in ACC
time, CPB time, or AF-free rate (Table 2).
Comparison 2: Maze procedure—Lt-maze vs. Bi-
maze
The clinical characteristics of patients in the Lt-
maze and Bi-maze groups are listed in Table 3, for
which there were no signiﬁcant diﬀerences. The AF-
free rates at hospital discharge were 76.1% and
86.2% in the Lt-maze and Bi-maze groups, respec-
tively, and there was no signiﬁcant diﬀerence
between these groups in ACC time, CPB time, and
AF-free rate. In those who received single valve
surgery, the AF rates at hospital discharge were
71.7% and 78.6% in the Lt-maze and Bi-maze
groups, respectively, and there was no signiﬁcant
diﬀerence between these groups in ACC time, CPB
time, and AF-free rate (Table 4).
AF predictor
A univariate analysis identiﬁed the preoperative
left atrial diameter (p ¼ 0:03), duration of preoper-
ative AF (p < 0:01), preoperative ﬁbrillation ampli-
tude on ECG (p ¼ 0:02), and preoperative cardio-
thoracic ratio (p < 0:01) as the signiﬁcant predictors
of AF at discharge. Duration of preoperative AF
was the only signiﬁcant predictor of AF at discharge
in multivariate analysis (Table 5). The perioperative
variables of ablation device, Maze procedure, ACC
time, and CPB time were not found to be signiﬁcant
predictors of AF at discharge.
Cost
For cryoablation, the initial cost including the
probes and operating console is approximately 7.3
million yen, and the running cost of the required
nitrous oxide gas is less than 14,000 yen/patient. For
unipolar RF ablation, the initial cost of the operating
console is approximately 2.1 million yen, and
running cost of the disposable probes is approx-
imately 250,000 yen/patient.
Discussion
Since the Maze procedure was introduced and
modiﬁed by Cox and colleagues, this unique tech-
nique has become widespread as a surgical treatment
Table 3 Patients’ characteristics in Maze-procedure com-
parison groups.
Lt-maze: n ¼ 71
(single valve:
n ¼ 46)
Bi-maze: n ¼ 29
(single valve:
n ¼ 14)
Age, years 60:3 10:0 58:7 9:1 N.S.
(58:1 10:4) (57:7 9:3) (N.S.)
Gender, M/F 36/35 20/9 N.S.
(21/25) (11/3) (p ¼ 0:03)
AF duration, 6:7 6:2 5:8 6:0 N.S.
years (6:9 6:1) (7:5 7:2) (N.S.)
Fibrillation 0:19 0:09 0:23 0:09 N.S.
amplitude, mV (0:19 0:08) (0:21 0:11) (N.S.)
LAD, mm 49:4 8:7 49:1 9:1 N.S.
(50:7 9:5) (51:4 8:1) (N.S.)
( ): subgroup with single valve surgery
Table 4 Operative results in Maze-procedure comparison.
Lt-maze Bi-maze
ACC time, min 129:3 34:2 131:8 41:7 N.S.
(121:9 25:4) (116:6 29:7) (N.S.)
CPB time, min 187:0 48:6 187:5 44:6 N.S.
(174:2 39:7) (178:9 46:7) (N.S.)
Deﬁbrillation rate, % 76:1 86:2 N.S.
(71:7) (78:6) (N.S.)
( ): subgroup with single valve surgery
Table 5 Predictor of postoperative AF.
Univariate Multivariate
p p Hazard
ratio
95% Conﬁdential
interval
Age 0:3239 0:865 0:992 0:908–1:084
Tricuspid annuloplasty 0:129 0:538 0:614 0:130–2:905
LAD 0:0289 0:283 0:952 0:870–1:042
Cardiothoracic ratio 0:0157 0:452 0:954 0:844–1:078
Duration of AF 0:0001 0:019 0:869 0:773–0:977
Fibrillation amplitude 0:0113 0:109 1579 0:193–12964
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for AF. Several modiﬁed procedures have been
performed and reported by several surgeons, such as
Kosakai and associates,12) Sueda and associates,4)
and Isobe and associates.13) However, the decision
to use Maze as the main procedure or additional
procedures varies between surgeons and institutions,
with this inﬂuencing not only the strategy and
concept of treatment for AF but also the results of
SR restoration. Furthermore, the results can be
inﬂuenced by the indication for the Maze procedure,
and hence the SR restoration rate after surgery would
be improved if the indication was accurately limited.
Our contra-indication was only a low amplitude of
the ﬁbrillation wave in electrocardiogram, because
postoperative persistent bradycardia, which some-
times resulted in permanent pacemaker implantation,
should be avoided; the ﬁne ﬁbrillation wave is
associated with atrial ﬁbrosis and more non-uniform
atrial excitement, namely electrical remodeling.14,15)
The maintenance of regular cardiac rhythm helps to
decrease the risk of thromboembolism and improve
cardiac function. Even if SR is maintained for only
several weeks after surgery, this provides the
advantage of stable hemodynamic management in
the postoperative recovery period.16) Therefore, we
have performed the Maze procedure as an additional
technique with wide indications.
In several published reports the SR restoration rate
ranges from 79% to 95%, and the mortality ranges
from 0% to 6.8%.17–20) We therefore consider our SR
restoration and mortality rates of 79% and 0%,
respectively, to be satisfactory.
The left atrial part of the Maze procedure was
focused on, and performed as the so-called Lt-maze.
The eﬃcacy of Lt-maze has already been reported on
by Sueda and colleagues. For patients with only a
right atrial focus, Lt-maze may bring little eﬀect.
However, most patients with AF can beneﬁt from Lt-
maze, since some studies have demonstrated that the
most common focus of AF is in the left atrium,
especially the area around the PVs.21,22) We select
Lt-maze except in cases with severe tricuspid valve
regurgitation. Since increased volume and/or ﬁlling
pressure in RA induced by tricuspid valve regur-
gitation and atrial septal defect bring on the thinning
and ﬁbrosis of myocardium and conducting ﬁbers
which lead to AF, we perform the Bi-maze proce-
dure.23–25) Although there are some reports of Lt-
maze reducing the ACC and CPB times, we found no
statistically signiﬁcant diﬀerences in these variables
between Lt-maze and Bi-maze. The reason for this is
that some ablation lesions of the right part of Bi-
maze could be created after aortic unclamp during
CPB weaning.
Predictors of persistent preoperative AF have been
reported by several investigators. In this study,
univariate logistic regression analysis showed that
a large left atrium, long duration of AF, low
ﬁbrillation amplitude at V1 on ECG, and high
cardiothoracic ratio are signiﬁcant predictors at
discharge; however, the multivariate logistic regres-
sion analysis showed that long duration of AF is a
signiﬁcant predictor. The long-term presence of AF
(i.e., over a period of years) causing atrial stretch
results in decreases in muscle volume and ﬁbrotic
changes in atria.23,26,27) AF can lead to an altered
patterns of connexins, changes in myocyte cellular
substructure, interstitial ﬁbrosis, and apoptotic atrial
myocyte death.28) Sinus node disease also shows
similar observations and low atrial voltage causing
pathophysiological change.29) Degeneration and/or
ﬁbrosis of atrium including sinus node and conduct-
ing ﬁber cause tissue inhomogeneity and nonuniform
atrial excitement. Fibroblast which is fairly depolar-
ized inﬂuences adjacent cell depolarization by an
electrotonic interaction. The degree of these atrial
changes reﬂects on the ﬁbrillation amplitude and
plays a role in the recurrence of AF and sinus node
disease after surgery.14,15,30–33) In order to reduce
complications, we carefully consider not only the AF
duration but also the ﬁbrillation amplitude for
contraindications in order to avoid postoperative
persistent bradycardia. In other words, a high
ﬁbrillation amplitude despite a long AF duration is
judged as an indication.
The ﬂexible probe of the unipolar RF ablation
system (which integrates multiple electrodes) can ﬁt
into the curved surface of the atrium and be used to
make a long ablation line. We expected that the RF
ablation system would result in short ACC and CPB
times. However, the absence of signiﬁcant diﬀer-
ences in these variables between cryoablation and
RF ablation in our study may be attributable to the
use of two cryoprobes simultaneously for the Maze
procedure with cryoablation.
It is important to note new risks associated with
unipolar RF ablation. Gillinov and colleagues,34) and
Mohr and colleagues35) reported esophageal injuries
associated with unipolar RF ablation, and micro-
embolization and hemostatic activation in percuta-
neous RF catheter ablation were reported by Anﬁn-
sen and colleagues,36) and Kok and colleagues.37)
Since it is possible that such complications occur in
the Maze procedure, we minimize the blood around
the RF probe and routinely irrigate the left atrium
with saline solution after RF ablation in order to
wash out char.
The ﬁnancial aspects of medical treatments also
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need to be considered. The initial cost of the
cryoablation system is more expensive than that of
the RF ablation system, however the running cost of
the RF ablation system is much higher than that of
the cryoablation system. According to simple ac-
counting of material cost in the RF ablation, the
advantage of the initial cost was oﬀset by the high
running cost of only 22 cases. Therefore it seems
reasonable to suppose that the cryoablation system
contributes to cost reduction. Japanese medical
insurance does not yet cover the expensive dispos-
able RF ablation probe. Although RF ablation is as
eﬀective as cryoablation, this RF ablation system
may not be economically appropriate in Japan—a
demonstration of the overwhelming superiority of
RF ablation may be necessary to obtain approval for
medical insurance coverage. Therefore, the RF
ablation probe is used for limited indications, such
as beating heart surgery, in our institution.
Regarding SR restoration rate in this series in
which all Maze procedures were performed with
arrested heart, there was no signiﬁcant diﬀerence
between RF ablation and cryoablation. However the
strategy of AF treatment will be changed by the use
of RF ablation, since it enables the Maze procedure
in the beating heart to be performed with an
epicardial approach; in contrast, it is impossible to
make a complete ablation lesion with cryoablation.
Additionally since it is possible to pace and measure
over the ablation line in the beating heart, this
procedure enable to conﬁrm the presence of atrial
wall conduction, and determine whether or not the
ablated block line is completed; this improves the
success rate of the Maze procedure.
Study limitations
This study was a retrospective analysis of a rather
small number of patients in the early postoperative
period, and hence the conclusions therefrom should
be limited to this period. Mid- and long-term data
should be analyzed and further follow-up is required
to evaluate the long-term eﬃcacy of the various
procedures.
Conclusion
Unipolar RF ablation for the Maze procedure is as
eﬀective as cryoablation at eliminating AF. How-
ever, the cost of the RF ablation probe needs to be
reduced. The Lt-maze and Bi-maze procedures are
equipotent at restoring SR at discharge, and the
preoperative duration of AF was the only detected
signiﬁcant predictor of AF recurrence.
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